BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25681036)

  • 21. MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Peng Y; Zhang X; Ma Q; Yan R; Qin Y; Zhao Y; Cheng Y; Yang M; Wang Q; Feng X; Huang Y; Huang W; Zhao Z; Wang L; Wei Y; He Z; Fan X; Li S; Jin Z; Meltzer SJ
    Cancer Lett; 2017 Jan; 385():117-127. PubMed ID: 27810403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
    Tian W; Zhu W; Jiang J
    Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
    Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
    Chen L; Wang X; Wang H; Li Y; Yan W; Han L; Zhang K; Zhang J; Wang Y; Feng Y; Pu P; Jiang T; Kang C; Jiang C
    Eur J Cancer; 2012 Nov; 48(16):3104-11. PubMed ID: 22406049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
    Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
    Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/β-catenin signaling pathway.
    Yan Y; Yan H; Wang Q; Zhang L; Liu Y; Yu H
    FEBS J; 2019 Jul; 286(13):2577-2592. PubMed ID: 30927504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.
    Qi Z; Cai S; Cai J; Chen L; Yao Y; Chen L; Mao Y
    BMC Neurol; 2016 Dec; 16(1):248. PubMed ID: 27905892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19.
    Zhang L; Cao Y; Jia D; Wei M
    Biochem Biophys Res Commun; 2019 Apr; 511(3):619-625. PubMed ID: 30826062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway.
    Zhang C; Yang X; Fu C; Liu X
    Gene; 2018 Sep; 672():172-179. PubMed ID: 29906532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.
    Li D; Wang Z; Chen Z; Lin L; Wang Y; Sailike D; Luo K; Du G; Xiang X; Jiafu GD
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):245-250. PubMed ID: 27815074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
    Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M
    J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.
    Yan Z; Che S; Wang J; Jiao Y; Wang C; Meng Q
    Tumour Biol; 2015 Jul; 36(7):5323-31. PubMed ID: 25672607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin.
    Peng Z; Wu T; Li Y; Xu Z; Zhang S; Liu B; Chen Q; Tian D
    Brain Res; 2016 Aug; 1644():53-61. PubMed ID: 27138069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma.
    Cui R; Guan Y; Sun C; Chen L; Bao Y; Li G; Qiu B; Meng X; Pang C; Wang Y
    Cancer Lett; 2016 Apr; 374(1):1-11. PubMed ID: 26854715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.